Novavax Debt-to-Equity Ratio Growth & History (NVAX)

Novavax's debt-to-equity ratio was 0.49 for fiscal 2020.

View full Novavax company overview

Novavax annual debt-to-equity ratio history

Novavax annual debt-to-equity ratio

Fiscal yearPeriod endedDebt-to-equity ratioChangeGrowth
20202020-12-310.49
20152015-12-310.00−0.00−48.61%
20142014-12-310.00−0.00−54.77%
20132013-12-310.010.00+57.93%
20122012-12-310.00

Novavax debt-to-equity ratio trends

Over the last five fiscal years, Novavax's debt-to-equity ratio increased from 0.00 to 0.49, a change of 0.49. The latest reported quarter, Q2 2025, shows 1.54.

About the metric

What the debt-to-equity ratio means

The debt-to-equity ratio compares interest-bearing debt with shareholders’ equity. It helps show how much debt financing a company uses relative to its accounting equity, but useful comparison levels vary by industry.

Calculation and source

How debt-to-equity is calculated

TickerStat calculates debt-to-equity as total interest-bearing debt divided by SEC-reported shareholders’ equity for the same balance-sheet date. Total liabilities are not treated as debt, and periods with non-positive equity are omitted. Fiscal periods can differ from calendar years, so exact period-end dates are included.

Review Novavax source filings ↗

Community posts

It’s quiet here.

No posts about NVAX yet. Start the conversation.

Write the first post